A recent study reported newly identified SMGs including NRG1, ERBB4, XIRP2, NBEA, COL14A1, CNBD1, ITGAV, and AKAP6 [32, 33] that should be included in the mutational spectrum analyzed in all patients with gastric cancer. This evidence concerns the gene XIRP2 and gastric cancer.